Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosing Validation of Tlando in Hypogonadal Men
NCT03242590Phase 3Completed
- Sponsor
- Lipocine Inc
- Start
- Dec 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of TSX-011 in Hypogonadism, sponsored by Lipocine Inc. Started Dec 2016; status: completed.
02
Drugs
TSX-011
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03242590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242590.